Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • KDP vs GSK✓SelectedUSD · GSKKDP vs GSK performance historyLatest closeAs of+0.63%11/18
Stock and ETF performance explorer

KDP vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+231.0%
GSK return
+101.2%
Excess return
+129.8%
Maximum drawdown
-36.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.6%-1.3%+2.0%+1.0%
7D-8.5%-3.1%-5.3%-7.8%
30D+1.6%-0.9%+2.5%+1.8%
3M+14.5%-4.2%+18.7%+15.5%
6M+20.7%-1.6%+22.3%+20.8%
YTD+29.0%+2.6%+26.4%+27.2%
1Y+31.7%+6.2%+25.5%+28.8%
3Y+20.4%+55.0%-34.5%+4.9%
5Y+12.4%+42.8%-30.4%-1.2%
10Y+231.0%+102.1%+128.8%+166.2%
All+231.0%+101.2%+129.8%+166.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling